Breaking News Instant updates and real-time market news.

MYGN

Myriad Genetics

$21.35

0.165 (0.78%)

14:59
10/09/16
10/09
14:59
10/09/16
14:59

Myriad Genetics says tumor test doubles patient identification

Myriad Genetics (MYGN) announced that its myChoice HRD test identified more than double the number of patients who may benefit from treatment with niraparib than were identified by germline BRCA testing alone. The myChoice HRD test was evaluated in the NOVA study of nirarapib, an investigational oral PARP inhibitor being developed by TESARO (TSRO). "Patients with ovarian cancer who tested positive with myChoice HRD experienced a clinically meaningful improvement in PFS. We estimate that myChoice HRD identifies more than double the number of patients who may benefit compared to germline BRCA testing alone," said Myriad.

  • 09

    Oct

MYGN Myriad Genetics
$21.35

0.165 (0.78%)

08/10/16
GABE
08/10/16
DOWNGRADE
GABE
Hold
Myriad Genetics downgraded to Hold from Buy at Gabelli
Gabelli analyst Sara Wojda downgraded Myriad Genetics to Hold following Q4 results and lowered her FY17 estimates to include the impact of the Assurex acquisition and declining hereditary cancer segment.
08/10/16
08/10/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. SunPower (SPWR) downgraded to Neutral from Overweight at JPMorgan, to Perform from Outperform at Oppenheimer, to Hold from Buy at Deutsche Bank, to Neutral from Buy at Janney Capital, to Neutral from Outperform at Credit Suisse, and to Market Perform from Outperform at Avondale. 2. Noble Corp. (NE) downgraded to Sell from Hold at Argus with analyst David Coleman saying the company is being hurt by declining offshore drilling activity, lower fleet utilization and falling day rates. 3. Wayfair (W) downgraded to Neutral from Buy at Goldman and to Neutral from Buy at BofA/Merrill. 4. Buffalo Wild Wings (BWLD) downgraded to Market Perform from Outperform at Raymond James with analyst Brian Vaccaro saying shares are fairly valued in the context of below average comp visibility in the near-term and largely discount the benefits of near-term potential activist proposals. 5. Myriad Genetics (MYGN) downgraded to Equal Weight from Overweight at Barclays, to Neutral from Overweight at Piper Jaffray, to Market Perform from Outperform at Wells Fargo, and to Hold from Buy at Gabelli. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/11/16
SPHN
08/11/16
NO CHANGE
Target $30
SPHN
Overweight
Myriad Genetics price target lowered to $30 from $47 at Stephens
Stephens analyst Drew Jones lowered his price target for Myriad Genetics to $30 from $47 after the company missed Q4 expectations slightly and issued "disappointing" 2017 guide. The analyst sees hereditary cancer as the "primary culprit," with sales turnover blamed for volume weakness. Further, Jones believes the lack of visibility into this weakness has created an overhang that will not be solved with "one decent quarter." He reiterates an Overweight rating on the shares.
08/29/16
BOFA
08/29/16
NO CHANGE
BOFA
Myriad Genetics loses BCBS of Nevada contract to LabCorp, says BofA/Merrill
Analysts at BofA Merrill Lynch noted that Myriad Genetics (MYGN) has lost an in-network contract with Blue Cross Blue Shield of Nevada to LabCorp (LH) and the firm expects Myriad shares to trade down following the news. The firm sees the potential for a continuation of this trend across other BCBS systems in other states.

TODAY'S FREE FLY STORIES

SAVE

Spirit Airlines

$34.01

1.31 (4.01%)

07:39
09/22/17
09/22
07:39
09/22/17
07:39
Conference/Events
Spirit Airlines to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

IBM

IBM

$145.26

-0.62 (-0.43%)

, WBA

Walgreens Boots Alliance

$78.20

-0.64 (-0.81%)

07:39
09/22/17
09/22
07:39
09/22/17
07:39
Hot Stocks
IBM announces new agreement with Walgreens to deploy IBM retail analytics »

IBM (IBM) announced a new…

IBM

IBM

$145.26

-0.62 (-0.43%)

WBA

Walgreens Boots Alliance

$78.20

-0.64 (-0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 23

    Sep

  • 22

    Oct

  • 25

    Oct

  • 15

    Nov

07:38
09/22/17
09/22
07:38
09/22/17
07:38
Conference/Events
Federal Reserve Bank of Dallas President participates in a conference »

Dallas Federal Reserve…

07:37
09/22/17
09/22
07:37
09/22/17
07:37
Conference/Events
Federal Reserve Bank of Kansas City President to speak at conference »

Kansas City Federal…

MYGN

Myriad Genetics

$33.61

0.1 (0.30%)

07:36
09/22/17
09/22
07:36
09/22/17
07:36
Recommendations
Myriad Genetics analyst commentary  »

Myriad Genetics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

VSAR

Versartis

$21.60

-0.25 (-1.14%)

07:35
09/22/17
09/22
07:35
09/22/17
07:35
Downgrade
Versartis rating change  »

Versartis downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

$13.41

-0.33 (-2.40%)

, MSFT

Microsoft

$74.21

-0.73 (-0.97%)

07:35
09/22/17
09/22
07:35
09/22/17
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

AMD

AMD

$13.41

-0.33 (-2.40%)

MSFT

Microsoft

$74.21

-0.73 (-0.97%)

INTC

Intel

$37.20

0.13 (0.35%)

ABBV

AbbVie

KMI

Kinder Morgan

$19.32

-0.45 (-2.28%)

GLNG

Golar LNG

$21.34

0.19 (0.90%)

HAS

Hasbro

$94.84

-0.68 (-0.71%)

MIK

Michaels

$21.38

-0.04 (-0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 23

    Sep

  • 27

    Sep

  • 02

    Oct

  • 05

    Oct

  • 22

    Oct

  • 23

    Oct

  • 08

    Nov

VSAR

Versartis

$21.60

-0.25 (-1.14%)

07:34
09/22/17
09/22
07:34
09/22/17
07:34
Downgrade
Versartis rating change  »

Versartis downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGRX

Agile Therapeutics

$3.77

0.04 (1.07%)

07:34
09/22/17
09/22
07:34
09/22/17
07:34
Initiation
Agile Therapeutics initiated  »

Agile Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Dec

SECO

Seeco Holding

07:33
09/22/17
09/22
07:33
09/22/17
07:33
Syndicate
Seeco Holding 8.5M share IPO priced at $13.00 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

AAXN

Axon

$22.80

-0.11 (-0.48%)

07:32
09/22/17
09/22
07:32
09/22/17
07:32
Hot Stocks
Axon receives multiple orders for TASER X26P, TASER X2 smart weapons »

Axon announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$35.91

-0.06 (-0.17%)

07:32
09/22/17
09/22
07:32
09/22/17
07:32
Recommendations
Micron analyst commentary  »

Micron's November…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

FGP

Ferrellgas Partners LP

$5.02

-0.13 (-2.52%)

, MDU

MDU Resources

$26.21

-0.19 (-0.72%)

07:32
09/22/17
09/22
07:32
09/22/17
07:32
Hot Stocks
Ferrellgas Partners LP appoints Doran Schwartz as CFO »

Ferrellgas Partners L.P.…

FGP

Ferrellgas Partners LP

$5.02

-0.13 (-2.52%)

MDU

MDU Resources

$26.21

-0.19 (-0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

FINL

Finish Line

$9.22

-0.21 (-2.23%)

07:31
09/22/17
09/22
07:31
09/22/17
07:31
Technical Analysis
Technical View: Finish Line drops after earnings and outlook »

Shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

PANW

Palo Alto Networks

$140.06

-1.69 (-1.19%)

07:31
09/22/17
09/22
07:31
09/22/17
07:31
Conference/Events
Palo Alto Networks to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 07

    Dec

  • 11

    Dec

QCOM

Qualcomm

$52.03

0.05 (0.10%)

, NXPI

NXP Semiconductors

$112.72

0.17 (0.15%)

07:31
09/22/17
09/22
07:31
09/22/17
07:31
Hot Stocks
Qualcomm extends cash tender offer for shares of NXP Semiconductors »

Qualcomm (QCOM) announced…

QCOM

Qualcomm

$52.03

0.05 (0.10%)

NXPI

NXP Semiconductors

$112.72

0.17 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

S

Sprint

, TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

07:31
09/22/17
09/22
07:31
09/22/17
07:31
Hot Stocks
Breaking Hot Stocks news story on Sprint, T-Mobile »

Sprint up 2.6% after…

S

Sprint

TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 16

    May

AZN

AstraZeneca

$32.81

-0.12 (-0.36%)

07:31
09/22/17
09/22
07:31
09/22/17
07:31
Upgrade
AstraZeneca rating change  »

AstraZeneca upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 08

    Nov

SXT

Sensient

$75.90

0.19 (0.25%)

07:30
09/22/17
09/22
07:30
09/22/17
07:30
Initiation
Sensient initiated  »

Sensient initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRVL

Marvell

, CAR

Avis Budget

$38.08

0.16 (0.42%)

07:30
09/22/17
09/22
07:30
09/22/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

MRVL

Marvell

CAR

Avis Budget

$38.08

0.16 (0.42%)

GIS

General Mills

$51.69

-0.48 (-0.92%)

FINL

Finish Line

$9.22

-0.21 (-2.23%)

HOG

Harley-Davidson

$47.96

-0.39 (-0.81%)

JBLU

JetBlue

$18.90

-0.35 (-1.82%)

MXWL

Maxwell

$4.97

-0.155 (-3.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 02

    Oct

  • 05

    Oct

  • 17

    Oct

  • 08

    Nov

TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

, S

Sprint

07:29
09/22/17
09/22
07:29
09/22/17
07:29
Periodicals
T-Mobile, Sprint close to agreeing on deal terms, Reuters reports »

T-Mobile (TMUS) and…

TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

S

Sprint

DTEGY

Deutsche Telekom

$18.36

-0.39 (-2.08%)

SFTBF

SoftBank

$81.50

-1.14 (-1.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 16

    May

EADSY

Airbus

$23.07

0.78 (3.50%)

, BA

Boeing

$256.04

0.58 (0.23%)

07:29
09/22/17
09/22
07:29
09/22/17
07:29
Periodicals
Turkish Airlines mulls Airbus order following Boeing deal, Reuters reports »

Turkish Airlines has…

EADSY

Airbus

$23.07

0.78 (3.50%)

BA

Boeing

$256.04

0.58 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

ASND

Ascendis Pharma

$27.74

-1.55 (-5.29%)

, VSAR

Versartis

$21.60

-0.25 (-1.14%)

07:28
09/22/17
09/22
07:28
09/22/17
07:28
Recommendations
Ascendis Pharma, Versartis analyst commentary  »

Ascendis Pharma price…

ASND

Ascendis Pharma

$27.74

-1.55 (-5.29%)

VSAR

Versartis

$21.60

-0.25 (-1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

07:28
09/22/17
09/22
07:28
09/22/17
07:28
Hot Stocks
Trump says greatest influence over election was 'Fake News Media' »

President Donald Trump…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

, S

Sprint

07:27
09/22/17
09/22
07:27
09/22/17
07:27
Periodicals
Breaking Periodicals news story on T-Mobile, Sprint, Deutsche Telekom, SoftBank »

T-Mobile, Sprint close to…

TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

S

Sprint

DTEGY

Deutsche Telekom

$18.36

-0.39 (-2.08%)

SFTBF

SoftBank

$81.50

-1.14 (-1.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 16

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.